Biotech · Private company
Medeor Therapeutics, Inc.
Track this companyFree. Adds Medeor Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MDR-101Phase 3 · Kidney Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
- MDR productImmune ToleranceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy ProductsTERMINATED · started May 11, 2022ClinicalTrials.gov NCT05010174 · fetched Nov 12, 2026
- Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney TransplantsPHASE3 · COMPLETED · started Mar 15, 2018ClinicalTrials.gov NCT03363945 · fetched Nov 12, 2026